174 related articles for article (PubMed ID: 19128162)
1. Class of antiretroviral therapy and CD4+ T cell count recovery: independence questioned.
Parienti JJ
Clin Infect Dis; 2009 Feb; 48(3):370; author reply 370-2. PubMed ID: 19128162
[No Abstract] [Full Text] [Related]
2. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
[TBL] [Abstract][Full Text] [Related]
3. [HIV infection: in the HAART era, CD4 makes the difference].
Varsky C
Acta Gastroenterol Latinoam; 2004; 34(3):117-9. PubMed ID: 15742925
[No Abstract] [Full Text] [Related]
4. Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy.
Ferraris L; Bellistri GM; Pegorer V; Tincati C; Meroni L; Galli M; Monforte Ad; Gori A; Marchetti G
Clin Infect Dis; 2008 Jan; 46(1):149-50. PubMed ID: 18171234
[No Abstract] [Full Text] [Related]
5. Twenty years of HIV-1 research: what the future holds.
Imami N; Gotch F
Nat Immunol; 2003 Jun; 4(6):501. PubMed ID: 12774067
[No Abstract] [Full Text] [Related]
6. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
[TBL] [Abstract][Full Text] [Related]
7. HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy.
Rauch A; Nolan D; Furrer H; McKinnon E; John M; Mallal S; Gaudieri S; Günthard HF; Schmid P; Battegay M; Hirschel B; Telenti A; James I;
Clin Infect Dis; 2008 Jun; 46(12):1921-5. PubMed ID: 18466093
[TBL] [Abstract][Full Text] [Related]
8. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.
Marchetti G; Bellistrì GM; Borghi E; Tincati C; Ferramosca S; La Francesca M; Morace G; Gori A; Monforte AD
AIDS; 2008 Oct; 22(15):2035-8. PubMed ID: 18784466
[TBL] [Abstract][Full Text] [Related]
9. Reduced levels of CD4 cell spontaneous apoptosis in human immunodeficiency virus-infected patients with discordant response to protease inhibitors.
Meroni L; Varchetta S; Manganaro D; Gatti N; Riva A; Monforte Ad; Galli M
J Infect Dis; 2002 Jul; 186(1):143-4. PubMed ID: 12089680
[No Abstract] [Full Text] [Related]
10. Immunological effects of antiretroviral and immune therapies for HIV.
Kelleher AD; Al-Harthi L; Landay AL
AIDS; 1997; 11 Suppl A():S149-55. PubMed ID: 9451979
[No Abstract] [Full Text] [Related]
11. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.
Gazzola L; Tincati C; Bellistrì GM; Monforte Ad; Marchetti G
Clin Infect Dis; 2009 Feb; 48(3):328-37. PubMed ID: 19123868
[TBL] [Abstract][Full Text] [Related]
12. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
Susaengrat W; Mitchai M; Leerattanapetch N
J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
Huang KH; Loutfy MR; Boulet S; Toma E; Tsoukas CM; Bernard NF
Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
[TBL] [Abstract][Full Text] [Related]
14. CD4 lymphocyte percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisited.
Goicoechea M; Haubrich R
J Infect Dis; 2005 Sep; 192(6):945-7. PubMed ID: 16107944
[No Abstract] [Full Text] [Related]
15. Simpler tests for immune cells could transform AIDS care in Africa.
Willyard C
Nat Med; 2007 Oct; 13(10):1131. PubMed ID: 17917650
[No Abstract] [Full Text] [Related]
16. Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor.
Grant P; Taylor J; Cain P; Short W; Gallant J; Farthing C; Thal G; Coakley E; Zolopa A
Clin Infect Dis; 2009 Mar; 48(5):680-2. PubMed ID: 19191657
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cell recovery with antiretroviral therapy: more than the sum of the parts.
Geng EH; Deeks SG
Clin Infect Dis; 2009 Feb; 48(3):362-4. PubMed ID: 19123869
[No Abstract] [Full Text] [Related]
18. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
Theze J
Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
[TBL] [Abstract][Full Text] [Related]
19. HIV results in the frame. CD4+ cell turnover.
Mosier DE
Nature; 1995 May; 375(6528):193-4; author reply 198. PubMed ID: 7746312
[No Abstract] [Full Text] [Related]
20. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]